February 15, 2018
On February 12, the 5th SCOR Young European Researcher Prize for Research into Alzheimer’s disease was presented to Erik Portelius of Sweden’s Gothenburg University, for his findings on a new biomarker that enables ea
February 9, 2018
Embracing the insurance opportunities offered by digital technology, SCOR Global Life partners with Vivametrica to develop a new risk model based on data from wearable devices.
January 17, 2018
Each year, SCOR rewards the best academic work in the field of actuarial science with prizes in several countries.
SCOR has been named “Reinsurer of the Year” for 2017 by InsuranceERM
SCOR has been named “Reinsurer of the Year” for 2017 by InsuranceERM
SCOR has completed the increase of its stake in MutRé S.A. to 100%.
SCOR has completed the increase of its stake in MutRé S.A. to 100%.
December 11, 2017
In a new inFORM publication, SCOR Life division experts Dephine Labojka and Dr. James Kadouch discuss the most common heart valve diseases, their etiology, and the efficiency of surgery.
Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
Die Prävalenz von Herzklappenerkrankungen in der Allgemeinbevölkerung ist mit ungefähr 2,5% niedrig. Bei den über 75-Jährigen liegt sie mit 10-15% wesentlich höher
December 6, 2017
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
